RETENTIONNCT07008729
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
At risk: Primary completion moved 2 months later, primary endpoint(s) modified.
See at-risk trials from Puerta de Hierro University Hospital
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 6 more changesShow less
- Eligibility criteria expanded, about 17 words
- Primary completion pushed from Aug 31, 2026 to Oct 31, 2026
- Study completion pushed from Aug 31, 2026 to Nov 30, 2026
- Secondary endpoints: 16 to 17
- Site details revised at 1 of 6 sites
- Publications: details revised at 12 of 12 entries
- Minor Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 450 to confirmed 390
- Site details revised at 6 of 6 sites
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (17)
Show 12 moreShow less
Arms and interventions
The RETENTION platform will offer to the clinician in the experimental arm all the data gathered by the devices (smart watch, scale, oximeter, blood pressure monitor, temperature, medication adherence, weather and pollution indexes). along with artificial intelligence recommendations.
Patients in the control group will be monitored but the data will not be available to the clinicians nor the artificial intelligence recommendations.
Devices: Heart monitoring tools (data revision)
Other: Control (Standard treatment)
Sites
6 sites in 4 countries
Greece 2, Spain 2, Germany 1, Italy 1